|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.100 USD | +2.50% |
|
+1.74% | -23.08% |
| 06-30 | Protara Therapeutics CMO Leonardo Viana Nicacio Resigns | MT |
| 06-29 | Protara Therapeutics, Inc. Announces Executive Changes, Effective June 26, 2026 | CI |
| Market Cap | 230M 200M 187M 171M 323M 21.95B 328M 2.19B 860M 10.97B 865M 846M 36.5B | P/E 2026 * |
-3.11x | P/E 2027 * | -2.8x |
|---|---|---|---|---|---|
| Enterprise Value | 230M 200M 187M 171M 323M 21.95B 328M 2.19B 860M 10.97B 865M 846M 36.5B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 230x |
| Free-Float |
97.58% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Protara Therapeutics, Inc.
| 1 day | +2.50% | ||
| 1 week | +1.74% | ||
| Current month | +4.59% | ||
| 1 month | +0.49% | ||
| 3 months | -27.56% | ||
| 6 months | -38.35% | ||
| Current year | -23.08% |
| 1 week | 3.87 |  | 4.12 |
| 1 month | 3.77 | | 4.37 |
| Current year | 3.62 | | 7.5 |
| 1 year | 2.97 | | 7.82 |
| 3 years | 1.04 | | 10.48 |
| 5 years | 1.04 | | 10.48 |
| 10 years | 1.04 | | 67.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jacqueline Zummo
CTO | Chief Tech/Sci/R&D Officer | 45 | 2019-02-28 |
Jesse Shefferman
CEO | Chief Executive Officer | 54 | 2017-10-31 |
Patrick Fabbio
DFI | Director of Finance/CFO | 58 | 2023-01-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Beshar
CHM | Chairman | 67 | 2019-12-31 |
Richard Levy
BRD | Director/Board Member | 68 | 2019-12-31 |
Gregory Sargen
BRD | Director/Board Member | 60 | 2019-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/30/26 | Don | Founder | -30,000 | 0.0534% | ||
| 6/15/26 | Free | Director | 31,000 | 0.0552% | ||
| 6/15/26 | Free | Director | 31,000 | 0.0552% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.50% | +1.74% | +31.83% | +69.42% | 230M | |
| -3.25% | +13.72% | +52.49% | +88.86% | 62.92B | |
| +2.41% | +3.62% | +34.07% | +74.62% | 54.32B | |
| -1.07% | -1.79% | -18.07% | -14.36% | 22.91B | |
| +33.86% | +30.60% | +19.14% | +502.77% | 28.73B | |
| +10.83% | +18.38% | +52.76% | +4.58% | 21.65B | |
| +8.55% | +9.87% | +41.17% | -19.64% | 17.76B | |
| -3.37% | +25.85% | +213.21% | +369.13% | 16.47B | |
| +6.20% | +11.51% | +34.94% | +681.88% | 15.48B | |
| -7.94% | -6.74% | +38.42% | +157.52% | 13.12B | |
| Average | +1.67% | +7.44% | +50.00% | +191.48% | 25.36B | |
| Weighted average by Cap. | +1.10% | +8.61% | +46.25% | +166.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 1M 868K 813K 743K 1.4M 95.26M 1.42M 9.51M 3.73M 47.59M 3.75M 3.67M 158M |
| Net income | -78.17M -67.84M -63.52M -58.11M -110M -7.45B -111M -743M -292M -3.72B -294M -287M -12.38B | -99M -85.92M -80.45M -73.59M -139M -9.43B -141M -941M -369M -4.71B -372M -364M -15.68B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-06 | US$4.100 | +2.50% | 329,339 |
| 26-08-05 | US$4.000 | -0.25% | 480,803 |
| 26-08-04 | US$4.010 | +1.01% | 425,772 |
| 26-08-03 | US$3.970 | +1.28% | 241,579 |
| 26-07-31 | US$3.920 | -2.73% | 294,633 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TARA Stock
Select your edition
All financial news and data tailored to specific country editions
